What are the alternative names for dasatinib (including brand name, code name, and salt form)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 14, 2026 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Alternative Names for Dasatinib

Dasatinib is also known by its code name BMS-354825 and is marketed under the brand name Sprycel®. 1, 2

Code Name

  • BMS-354825 was the developmental code name used during clinical trials before FDA approval 1, 3

Brand Name

  • Sprycel® is the registered trademark brand name under which dasatinib is commercially marketed by Bristol-Myers Squibb 2, 3

Chemical Form

  • Dasatinib is formulated as a monohydrate with the molecular formula C22H26ClN7O2S•H2O, corresponding to a formula weight of 506.02 4
  • The anhydrous free base has a molecular weight of 488.01 4
  • The full chemical name is N-(2-chloro-6-methylphenyl)-2-[[6-[4-(2-hydroxyethyl)-1-piperazinyl]-2-methyl-4-pyrimidinyl]amino]-5-thiazolecarboxamide, monohydrate 4

Clinical Trial Designation

  • In clinical studies, dasatinib was evaluated under the START trial program (SRC/ABL Tyrosine Kinase Inhibition Activity: Research Trials of Dasatinib), including START-C and START-A trials 1

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

3
Research

Dasatinib: BMS 354825.

Drugs in R&D, 2006

Related Questions

What are the adverse effects of Dasatinib (Sprycel)?
What is the dosage of Sprycel (dasatinib)?
Should a patient with Philadelphia chromosome-positive Chronic Myeloid Leukemia (Ph+-CML) continue on Sprycel (dasatinib) 100mg with persistent neutropenia and lack of significant improvement in White Blood Cell (WBC) count?
In a generally healthy reproductive‑age woman without clotting medication use, hormone‑sensitive cancer, uncontrolled thyroid disease, or severe liver/kidney disease, is Proov Pro supplement safe and appropriate for luteal‑phase support to improve implantation?
What is the recommended management for hyperkalemia in a patient with a serum potassium of 6.5 mEq/L and ECG changes (or 6.0–6.5 mEq/L without ECG changes)?
What is the maximum recommended duration of phentermine therapy for a patient?
Can amoxicillin be given together with methotrexate in an adult patient on low‑to‑moderate weekly methotrexate (7.5–25 mg) for rheumatoid arthritis with normal renal function?
Is it safe for a woman in the luteal phase who is taking prescribed progesterone to also take the Proov Pro supplement?
What is osmotic diuresis, what are its common causes, clinical manifestations, and how should it be managed?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question